MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurheartj/ehaf097

Медицинская библиотека · European heart journal · 2025

The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.

Dang Quan M, Psaltis Peter J, Burgess Sonya, Chandrasekhar Jaya, Mukherjee Swati, Kritharides Leonard, Jepson Nigel, Fairley Sarah, Ihdayhid Abdul, Layland Jamie, Szirt Richard, El-Jack Seif, Puri Aniket, Davis Esther, Shiekh Imran, Arnold Ruth, Watts Monique, Marathe Jessica A, Bhagwandeen Rohan, Wing-Lun Edwina, Bhindi Ravinay, Ford Tom, Lo Sidney, Marschner Simone, Zaman Sarah

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndrome (ACS). Recent data suggest a harmful association of dual antiplatelet therapy compared with single antiplatelet therapy following SCAD. This study investigated independent predictors of major adverse cardiovascular events (MACEs) and recurrence in patients with SCAD.

METHODS

This multicentre cohort study involving 23 Australian and New Zealand sites included patients aged ≥18 years with an ACS due to SCAD confirmed on core laboratory adjudication. Multivariable Cox proportional hazard models analysed predictors for the primary MACE outcome.

RESULTS

Among 586 patients, 505 (150 prospective, 355 retrospective) with SCAD confirmed by core laboratory adjudication, mean age was 52.2 ± 10.6 years, 88.6% were female, and 74.5% were Caucasian. At long-term follow-up (median 21 months), MACE and SCAD recurrence occurred in 8.6% and 3.6% of patients, respectively. Oral anticoagulation on discharge [adjusted hazard ratio (aHR) 3.8, 95% confidence interval (CI) 1.6-9.3, P = .003], ticagrelor combined with aspirin (aHR 1.8, 95% CI 1.04-3.2, P = .037), fibromuscular dysplasia (aHR 2.2, 95% CI 1.05-4.5, P = .037), and history of stroke (aHR 3.8, 95% CI 1.2-12.2, P = .03) were independently associated with higher MACE. Fibromuscular dysplasia (aHR 3.9, 95% CI 1.5-26.5, P = .01), ticagrelor combined with aspirin (aHR 2.6, 95% CI 2.1-5.3, P = .01), and history of stroke (aHR 6.2, 95% CI 1.8-9.5, P = .01) were also associated with higher SCAD recurrence.

CONCLUSIONS

The findings support the hypothesis that SCAD is primarily caused by intramural bleeding, with a harmful association of more potent antiplatelet therapy and anticoagulation with adverse cardiovascular outcomes.

Для цитирования: Dang Quan M, Psaltis Peter J, Burgess Sonya, Chandrasekhar Jaya, Mukherjee Swati, Kritharides Leonard, Jepson Nigel, Fairley Sarah, Ihdayhid Abdul, Layland Jamie, Szirt Richard, El-Jack Seif, Puri Aniket, Davis Esther, Shiekh Imran, Arnold Ruth, Watts Monique, Marathe Jessica A, Bhagwandeen Rohan, Wing-Lun Edwina, Bhindi Ravinay, Ford Tom, Lo Sidney, Marschner Simone, Zaman Sarah. The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.. European heart journal. 2025. DOI: 10.1093/eurheartj/ehaf097.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.